The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.Yunnan Nengtou: It is planned to invest in Yongning wind farm expansion project. Yunnan Nengtou announced that Maitreya Company, a wholly-owned subsidiary, plans to invest in Yongning wind farm expansion project (Maitreya area), with a total installed capacity of 230,000 kilowatts and a total investment of 1.323 billion yuan (including 6.9 million yuan in working capital). On the same day, it was announced that Honghe Company, a wholly-owned subsidiary, planned to invest in the Yongning Wind Farm Expansion Project (Luxi Area), with a total installed capacity of 235,000 kilowatts and a total investment of 1.395 billion yuan (including 7.05 million yuan in working capital).Jinghe Jicheng: Shareholder Lijing Venture Capital intends to transfer 1.50% shares of the company by inquiry, and Jinghe Jicheng announced that shareholder Lijing Venture Capital intends to transfer 30.092 million shares of the company by inquiry transfer, accounting for 1.50% of the company's total share capital.
The EUR/USD of the euro against the US dollar rose by 0.50% in the day and is now reported at 1.0518.Donghua Technology: Inner Mongolia New Materials, a holding subsidiary, signed a product sales contract with Yulin Chemical of Shaanxi Coal Group. Donghua Technology announced that China National Chemical New Materials Co., Ltd., a holding subsidiary, plans to sign a Product Sales Contract with Yulin Chemical Co., Ltd. of Shaanxi Coal Group, stipulating that Yulin Chemical will sell ethylene glycol and by-products produced by Inner Mongolia New Materials. The contract is from October 20, 2024 to December 31, 2025. Product prices are divided into temporary pricing and settlement price, and are priced according to the principle of marketization. From the beginning of 2024 to the disclosure date, the Company had related transactions with Yulin Chemical and its concerted parties, mainly to provide engineering services to Yulin Chemical and its concerted parties, with the related transactions amounting to 438 million yuan.Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.
Huitai Medical: Using raised funds and self-owned funds to increase capital of 700 million yuan to wholly-owned subsidiaries. Huitai Medical announced that the company held the 20th meeting of the second board of directors and the 17th meeting of the second board of supervisors on December 12, 2024, and reviewed and approved the Proposal on Using raised funds and self-owned funds to increase capital to wholly-owned subsidiaries. The company agreed to increase its capital by 700 million yuan to Shanghai Hongtong Industrial Co., Ltd., a wholly-owned subsidiary, of which 438 million yuan of interest-bearing loans provided to Shanghai Hongtong with raised funds were converted into capital increase, and 262 million yuan was increased with its own funds. After the capital increase is completed, the registered capital of Shanghai Hongtong will increase from RMB 18,489,300 to RMB 26,548,200, and it will remain a wholly-owned subsidiary of the company.Shanghai Shipping Exchange: The transportation demand of Persian Gulf routes remained high, and the market freight rate continued to rise this week. On December 13th, according to the news of Shanghai Shipping Exchange, this week, the export container transportation market in China was basically stable, and different routes were divided due to their different trends of supply and demand fundamentals, and the comprehensive index rose. On European routes, the growth of transportation demand is weak, the fundamentals of supply and demand lack further support, and the booking price in the spot market drops slightly. On the North American route, the transportation demand is generally stable, and the relationship between supply and demand is basically balanced. Major airlines push the freight rate up, and the spot market booking price rises sharply. On the Persian Gulf route, the transportation demand remained high, and the market freight rate continued to be supported by the local tension. This week, the market freight rate continued to rise. On the Australia-New Zealand route, the local demand for various materials showed signs of stabilization, the fundamentals of supply and demand improved, and the market freight rate stopped falling and rebounded. On the South American route, the transportation demand lacks the motivation for further growth, and the fundamentals of supply and demand weaken. This week, the spot market booking price dropped slightly.Niu San "husband and wife file", placard North Exchange Company, recently, "perfume king" Zhou Xingang, sold to North Exchange Company. On the evening of December 12th, Ricky Zhizao announced that from November 6th to December 11th, Zhou Xingang and Xin Li increased their holdings of about 7,605,400 shares in the company through centralized bidding, accounting for 5.4125% of the company's total share capital. Zhou Xingang and Xin Li are husband and wife, who act in concert. (SSE)
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide